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Few families of signaling factors have been impli-
cated in the control of development. Here, we identify
the neuropeptides nociceptin and somatostatin, a
neurotransmitter and neuroendocrine hormone, as a
class of developmental signals in both chick and
zebrafish. We show that signals from the anterior
mesendoderm are required for the formation of ante-
rior placodeprogenitors,withoneof the signalsbeing
somatostatin. Somatostatin controls ectodermal
expression of nociceptin, and both peptides regulate
Pax6 in lens andolfactoryprogenitors.Consequently,
lossof somatostatin andnociceptin signaling leads to
severe reduction of lens formation. Our findings not
only uncover these neuropeptides as developmental
signals but also identify a long-sought-after mecha-
nism that initiates Pax6 in placode progenitors and
may explain the ancient evolutionary origin of neuro-
peptides, predating a complex nervous system.
INTRODUCTION
In the vertebrate head, multipotent progenitor cells give rise to
crucial components of sense organs and sensory ganglia
(Schlosser, 2010; Streit, 2007). They reside in the ectoderm
next to the anterior neural plate, where they are induced by
FGFs combined with Wnt and BMP attenuation (Ahrens and
Schlosser, 2005; Brugmann et al., 2004; Litsiou et al., 2005).
Although they generate cells as diverse as lens fibers and olfac-
tory sensory neurons, they are initially competent to formanypla-
code and share a common developmental program: at neurula
stages, all sensory progenitors are specified as lens and diversify
later under the influence of inductive signals fromsurrounding tis-
sues (Bailey et al., 2006; Baker et al., 1999; Bhattacharyya and
Bronner-Fraser, 2008; Gallagher et al., 1996; Groves and Bron-
ner-Fraser, 2000; Henry and Grainger, 1987; Jacobson, 1963;
Martin and Groves, 2006; Schlosser, 2010; Streit, 2007).
One of the key factors initiating the lens program is the paired
box transcription factor Pax6 (Cvekl and Duncan, 2007; Lang,
2004). Consistent with its expression in lens and olfactory pre-
cursors (anterior placode progenitors [aPPs]), Pax6 mutationsDevein humans and mice lead to severe eye and olfactory abnormal-
ities (Grindley et al., 1995; van Heyningen andWilliamson, 2002).
Indeed, Pax6 is one of the most striking examples of a master
regulator: its misexpression not only induces ectopic eyes in flies
and vertebrates, but its function is so conserved that vertebrate
Pax6 does so in Drosophila (Chow et al., 1999; Halder et al.,
1995). It is therefore surprising that the tissues and signals that
initiate Pax6 expression—and thus aPP specification—are
unknown. Here, we demonstrate that the anterior mesendoderm
is required for aPP formation and regulates Pax6. It does so by
secreting the neuropeptide somatostatin (SST), which in turn
activates nociceptin (Noc) in the overlying ectoderm. Together,
these neuropeptides control aPP fate as an early step in lens
and olfactory epithelium development.
RESULTS
Identification of Somatostatin and Nociceptin
as Potential Developmental Signals
Consistent with its function, Pax6 is initially confined to future
lens and olfactory cells (aPPs). However, chick posterior placode
progenitors (pPPs; inner ear and epibranchial ganglia) upregu-
latePax6within only 5 hr when cultured in isolation and ultimately
turn into lenses (Bailey et al., 2006), providing an experimental
paradigm to screen for new Pax6 regulators. Transcriptome
comparison of four different cell populations (HH6 aPPs and
pPPs before and after 5 hr culture) reveals 136 Pax6 coregulated
transcripts. Among these, only four encode signaling molecules,
including the propeptide for the opioid-related Noc (Figure S1
available online); the receptor for another neuropeptide, SST, is
enriched in aPPs. This raises the intriguing possibility that in
addition to their well-known functions in the adult nervous sys-
tem and neuroendocrine modulation (Gahete et al., 2010), they
may also play a role during development.
We therefore surveyed the expression of Noc and SST and
their receptors from primitive streak to early somite stages.
The SST prepropeptide and the processed peptide are
expressed in the anterior mesendoderm underlying Pax6+
aPPs (Figures 1A–1C, 1A0, S1Ca–S1Cf, S2A, and S2B). In
contrast, its receptor SSTR5 and Noc (Figures 1D–1I, 1F0, and
1H0) are restricted to aPPs in the overlying ectoderm, where
they colocalize with Pax6 (Figures 1J–1L); both are downregu-
lated rapidly in aPPs after the HH8. Thus, Noc and SSTR5 repre-
sent aPP-specific transcripts. Like Noc mRNA, the processedlopmental Cell 26, 195–203, July 29, 2013 ª2013 Elsevier Inc. 195
Figure 1. Expression of SST, SSTR5, Noc,
and Pax6
In situ hybridization for SST (A–C ventral view;
A0 transverse section), SSTR5 (D–F dorsal view; F0
transverse section), Noc (G–I dorsal view; I0
transverse section), and Pax6 (J–L dorsal view).
Stages are indicated in the right corner of each
panel. Black lines in (A)–(L) indicate the level of the
sections. aPP, anterior placode progenitors; me,
mesendoderm; np, neural plate; nt: neural tube.
See also Figure S1.
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signaling is mediated by its cognate G protein-coupled receptor
opiate receptor-like 1 (OPRL1) and, due to a change in the N-ter-
minal amino acid in most nonmammalian vertebrates, by d, k,
and m opioid receptors (Danielson et al., 2001) (Figures S1Aa
and S1Ab). At neural plate stages, all opioid and other SST196 Developmental Cell 26, 195–203, July 29, 2013 ª2013 Elsevier Inc.(STTR1, STTR3, STTR4) receptors are
broadly expressed in the ectoderm
including placode progenitors (Figures
S2Ac–S2Aj and S3Aa–S3Al). Thus, the
expression of both neuropeptides and
their receptors is consistent with a role
in initiating Pax6 expression and in spec-
ifying progenitors for the olfactory epithe-
lium and the crystalline lens.
Somatostatin Signaling from the
Anterior Mesendoderm Promotes
Placode Progenitor Fate
SST is expressed in the anterior mesen-
doderm, a tissue implicated in forebrain
patterning (Dale et al., 1997; Foley et al.,
1997; Wilson and Houart, 2004; Withing-
ton et al., 2001). To test whether mesen-
doderm-derived signals are required for
aPP identity, we ablated this tissue unilat-
erally in HH4+/HH5 embryos (Figures
2A, S2Ba, and S2Bb). We find that Pax6
(1 out of 14, 7% Pax6+; Figures 2B and
2B0) and the general PP marker Eya2
(0 out of 4 Eya2+; Figure S2Be) are absent
5–6 hr thereafter, whereas sham-oper-
ated embryos are normal (Figure S2Bf).
Likewise, Noc transcripts are reduced at
5–6 hr and completely lost 16 hr after
ablation (0 out of 7 Noc+; Figures 2C
and 2C0), as is SSTR5 (0 out of 9 SSTR+;
Figures 2D and 2D0). In contrast, the pos-
terior ectoderm marker Gbx2 (n = 4) and
nonneural ectoderm marker Dlx5 (n = 4)
are unaffected (Figures S2C and S2D).
Can SST rescue the expression of aPP
markers? After mesendoderm removal,
local exposure to SST-, but not DMSO-,
coated beads (Figures S2Bg–S2Bh0)
rescues Pax6 (3 out of 3 Pax6+; Figures2E–2E00) and Noc expression (5 out of 5 Noc+; Figures 2F
and 2F0) after 16 hr culture. Thus, the anterior mesendoderm
provides key signals to promote aPP identity, SST being one of
these signals.
To assess whether SST signaling is required for aPP char-
acter, we used two different approaches. First, HH4 embryos
Figure 2. SST Is Required for aPP Character
(A) Unilateral ablation of axial and paraxial mesendoderm (red line); light gray indicates mid- and hindgut endoderm, and gray shows foregut endoderm.
(B–F)Pax6 (B and B0),Noc (C andC0), andSSTR5 (D and D0) after mesendoderm ablation (dotted lines); Pax6 (E and E0) andNoc (F and F0) after mesoderm ablation
and SST bead graft. SST-coated beads (*) restorePax6 (E–E00) andNoc (F and F0) after ablation (arrowheads). Lines in (B)–(F) indicate the level of sections shown in
(A0)–(E0).
(G and H) Pax6 after DMSO (G) or CSST (H) treatment.
(I–N)Pax6 (I and J),Noc (K and L), and Eya2 (M, N, and N0) in SSTR5morphants. (J), (L), and (N) show the same embryos as in (I), (K), and (M), respectively, afterMO
detection (brown).
See also Figure S2.
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(CSST) or vehicle control (DMSO). At HH6/HH7, Pax6 expres-
sion is absent in CSST (4 out of 18, 22% Pax6+; Figure 2H)
but present in DMSO-treated controls (6 out of 6 Pax6+; Fig-
ure 2G). Second, we asked whether the receptor SSTR5 medi-
ates SST function. Control or SSTR5 translation-blocking
morpholinos (MOs) were electroporated into future aPPs at
HH4. Like mesendoderm ablation, SSTR5 knockdown leads
to a loss of Pax6 (1 out of 13, 8% Pax6+; Figures 2I and 2J),
Noc (5 out of 19, 26% Noc+; Figures 2K and 2L), and Eya2
(0 out of 6 Eya2+; Figures 2M, 2N, and 2N0) at HH6-8, whereas
control MOs have no effect (Figures S2Bi–S2Bn). Together,
these results show that SST signaling from the anterior mesen-
doderm is crucial for the specification of lens and olfactory
progenitors by controlling the onset of Pax6 and other PP-
specific transcripts.DeveSignals from the Posterior HeadMesodermRepress aPP
Markers
Although Pax6 and Noc are upregulated in explanted pPPs (Fig-
ures S1 and 3A), they are restricted to the aPP region in the
embryo (Figure 1), suggesting that anterior fates are actively
repressed in vivo. A possible source for such repressive signals
is the mesoderm underlying pPPs. To test this, we analyzed
Pax6 and Noc expression in pPP explants cultured with and
without posterior mesoderm (pM). Indeed, we find that both
transcripts are repressed by mesoderm-derived signals (Fig-
ure 3Aa). pPPs normally give rise to otic and epibranchial
placodes with FGFs being potent inducers of a common otic-
epibranchial progenitor domain (Freter et al., 2008; Groves
and Bronner-Fraser, 2000; Martin and Groves, 2006; Yang
et al., 2013). To test whether FGF signaling is sufficient for
aPP inhibition, we cultured pPP explants with FGF2; thislopmental Cell 26, 195–203, July 29, 2013 ª2013 Elsevier Inc. 197
Figure 3. Noc Is Required for aPP Character
(A) Regulation of aPP markers in vitro. (a) Quantification of Noc and Pax6 expression by NanoString nCounter in pPP explants cultured alone (black), with FGF2
(red), with posterior head mesoderm (pM; gray), or with posterior head mesoderm and SU5402 (blue). Bars represent means of normalized values ± SE. The
asterisk (*) indicates significant differences: p < 0.05. (b) Cultured pPP explants initiate Noc. (c and d) Pax6 after DMSO (c) or TRAP101 (d) treatment. (e–g) Pax6 in
explants cultured with controlMOs (e), Noc splice-blockingMOs (f), or NocMOs and peptide (g). (h) Graph showing Noc knockdown effect on Pax6 andSix1. Bars
represent mean values ± SE. The asterisk (*) indicates significant differences: p < 0.05. See also Figure S3.
(B) Noc is required for aPP fate in vivo. (a and b) HH4+/HH5 embryos cultured for 12 hr in DMSO (a) or opioid receptor inhibitors (b; N/U: naloxone, UFP101).
(c and d) Pax6 in HH4+/HH5 embryos treated with DMSO (c) or CSST (C) for 36 hr, naloxone (N) and UFP101 (U); compare brackets in (c) and (d). (e–h) d-crystallin
expression in embryos cultured for 60 hr fromHH4+/HH5with DMSO (e) or CSST (C), naloxone, and UFP101 (f–h). (f)–(h) show the range of phenotypes, and (e0)–
(h00) show sections through the left and right lens (L) regions of the same embryos shown in (e)–(h). OV, optic vesicle. (i–k0) After electroporation of Noc ATGMOs at
HH4, embryos were cultured for 10 hr (i and i0, and k and k0) or 18 hr (j and j0). Brown (i0 and k0) and green (j0) indicate electroporated cells.
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(Freter et al., 2008; Groves and Bronner-Fraser, 2000; Martin
and Groves, 2006; Yang et al., 2013). Although Noc expression
does not change significantly when compared to controls, Pax6
is significantly repressed (Figure 3Aa). To test whether meso-
derm-derived FGF signaling is required for Pax6 repression,
we treated pPP/pM explants with the FGF antagonist SU5402;198 Developmental Cell 26, 195–203, July 29, 2013 ª2013 Elsevier Inthis rescues Pax6 expression partially but does not restore the
expression levels observed in the absence of mesoderm (Fig-
ure 3Aa). Together, these findings show that posterior head
mesoderm plays a role in patterning the placodal domain by
simultaneously promoting posterior and repressing anterior
character. Although FGF signaling is involved in this process,
other unidentified pathways must cooperate.c.
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Noc was identified as a Pax6 coregulated gene (Figure S1); both
genes are coexpressed in aPPs (Figure 1), and like Pax6, Noc is
rapidly upregulated in explanted pPPs (n = 19 out of 22; 86%
Noc+; Figure 3Ab). To test whether Pax6 upregulation depends
on Noc signaling, we used an OPRL1 antagonist. Pax6 tran-
scripts are present in DMSO-treated control pPP explants (17
out of 23, 73%Pax6+; Figure 3Ac) but absent whenNoc signaling
is inhibited (11 out of 31, 35% Pax6+; Figure 3Ad). Likewise, Noc
splice MOs, but not control MOs, prevent Pax6 initiation (Figures
3Ae, 3Af, and 3Ah; controls, 39 out of 64, 61% Pax6+; experi-
mental, 27 out of 73, 34% Pax6+). This effect is rescued by the
addition of Noc peptide (13 out of 17, 76% Pax6+; Figures 3Ag,
3Ah, and S3Ca), demonstrating the specificity of the MOs. In
contrast, the generic PP marker Six1 does not change after
Noc knockdown (Figure 3Ah, 23 out of 23 Six1+; Figure S3Ca),
indicating that Noc specifically promotes anterior character.
To confirm that Noc is required for aPP specification in vivo, we
used two strategies. First, HH4 chick embryos were treated with
OPRL1andopiate receptor antagonists; this leads to loss ofPax6
at HH6 (Figure 3Bb; 0 out of 8 Pax6+), unlike DMSO-treated
controls (Figure 3Ba; 8 out of 11, 72% Pax6+). Second, we elec-
troporated translation- or splice-blocking Noc MOs, alone or in
combination, into stage HH4 chick embryos, targeting future
lens and olfactory cells. These produce identical phenotypes:
at early somite stages, theexpression of general placodeprogen-
itor markers (Figures S3Be–S3Bh0; Six1+, n = 8; Eya2+, n = 7), the
neural crestmarkerPax7 (Figures S3Ba, S3Bb, and S3Bb’; n = 5),
and Otx2 (Figures S3Bc, S3Bd, and S3Bd0; n = 7), an anterior
ectoderm marker expressed prior to Pax6 and Noc, are all unaf-
fected. However, like in vitro, in Nocmorphants, Pax6 is severely
reduced in lens and olfactory progenitors at head process and
early somite stages (Figures 3Bi–3Bj0, 4 out of 14, 29% Pax6+;
Figure S3Cb) as is Noc itself (0 out of 4 Noc+; Figures 3Bj and
3Bj0), whereas control MOs have little effect (Figures S2I–S2L;
7 out of 10, 70% Pax6+; 7 out of 11, 64% Noc+). In contrast, the
CNS domain of Pax6 is unaffected as is the expression of Six3
(n = 9; data not shown) and Ganf (n = 2; data not shown) in the
forebrain. Thus, Noc does not influence neural plate formation
but is required to regulate anterior placode fates by controlling
its own expression and that of the master regulator Pax6.
So far, our results show that mesendoderm-derived SST initi-
atesNoc expression in the overlying ectoderm and that both sig-
nals are required for aPP-specific gene expression. Do SST and
Noc act in a linear pathway? If so, nociceptin should rescue the
SST phenotype. We therefore ablated anterior mesendoderm
(the source of SST) or knocked down SSTR5 followed by a graft
of Noc-coated beads. Activation of Noc signaling does not
rescue Pax6 expression in the absence of SST (Figure S3D;
n = 13). Thus, the two neuropeptides act in parallel, and both
are required for Pax6 expression and, consequently, for aPP
specification.
Lens Defects in the Absence of SST and Noc Signaling
SST and Noc are transiently expressed in the anterior mesen-
doderm and anterior preplacodal ectoderm, respectively, and
participate in aPP specification by regulating Pax6 (see above).
Does the loss of aPP character affect placode formation at later
stages? To assess this, we treated embryos with inhibitors ofDeveNoc and SST signaling starting at HH4/HH5. This reduces
Pax6 in the surface ectoderm, but not in the brain, at HH10/
HH11 (Figures 3Bc and 3Bd; 7 out of 14, 50% Pax6 reduction;
controls: 13 out of 14, 93% normal). At embryonic day 3 (E3),
phenotypes vary slightly, with only 12.4% (n = 24) showing
normal expression of the lens differentiation marker d-crystallin
compared to 70% of DMSO-treated controls (n = 20). Lens plac-
odes or vesicles are absent uni- (12.4%) or bilaterally (16.6%) or
are substantially smaller (58.3%; Figures 3Bf–3Bh and 3Bf0–
3Bh00) than in controls (Figures 3Be and 3Be0; n = 20; 30% with
unilateral small placode). Although patches of d-crystallin show
typical placode morphology, they remain small and never invag-
inate to form a vesicle. In severe cases, optic vesicle morphology
is affected because lens-derived signals are required for its
normal development (Coulombre and Coulombre, 1964; Yama-
moto and Jeffery, 2000; Chow and Lang, 2001). Thus, SST and
Noc signaling are critical for aPP specification and therefore
for normal lens formation.
Somatostatin and Nociceptin Functions Are Conserved
in Zebrafish
To assess whether neuropeptide function in anterior placode
precursor formation is conserved across species, we turned to
zebrafish and cloned prepronociceptin b (pnocb). As in chick,
pnocb is coexpressed with Pax6b in aPPs (Figures 4A and 4B),
whereas SST1 (Devos et al., 2002) is expressed in the mesendo-
derm (Figure 4C). Like in chick, inhibition of SST signaling using
the antagonist CSST leads to disruption of Pax6b at neural plate
stages in a dose-dependent manner (Figures 4D, 4E, and 4O).
Noc knockdown using two different MOs alone or in combination
results in uni- or bilateral reduction ofPax6b (Figures 4G, 4H, and
4O; 32 out of 171, 19% normal Pax6b) and Pitx3 (Figure 4P; 5 out
of 58, 9% Pitx3+) in aPPs at neural plate stages. Pax6b expres-
sion is rescued by growing morphants in the presence of Noc
peptide (Figures 4I–4K and 4O). In pnocbmorphants, the general
PP markers Eya1 and Six1 are unaffected (data not shown), sug-
gesting that, like in chick, aPPs retain placode progenitor identity
but lose their anterior character. In contrast to Pax6b reduction in
aPPs, its expression in the neural plate is unaffected, as are the
neural markers Rx3, Emx1, Six3, and Irxb until at least the ten-
somite stage (data not shown; n > 25 for each marker). These
results show that nociceptin signaling primarily affects placode,
but not neural plate, development.
Consistent with the loss of early Pax6b, Noc morphants show
variable eye phenotypes after 24 hr: their lenses are smaller,
asymmetric, or absent (n = 84; Figures 4L–4N and 4P), and as
a consequence, the optic vesicles are reduced in size. Simulta-
neous inhibition of SST and Noc phenocopies the loss of each
pathway individually (n = 54; data not shown). Thus, like in chick,
Noc is coexpressed with Pax6b in placode progenitors at the
border of the anterior neural plate, whereas SST1 is expressed
in the underlying mesendoderm. Both contribute to the specifi-
cation of aPPs, and their loss leads to abnormal eye develop-
ment in chick and zebrafish.
DISCUSSION
Our findings reveal a function for the anterior mesendoderm in
controlling aPP fates as an early step for lens and olfactorylopmental Cell 26, 195–203, July 29, 2013 ª2013 Elsevier Inc. 199
Figure 4. SST and Noc Control aPPs in Zebrafish
(A–C) Expression of Pax6b (A), pnocb (B), and SST1 (C) in zebrafish at early somite stages: dorsal views, anterior to the left.
(D and E) Pax6b reduction by CSST (E; arrowhead), but not by DMSO (D; white arrowhead).
(F–H) Embryos were injected with control (F) or pnocb MOs (G and H); the latter show Pax6b reduction (arrowheads in G and H). Dotted lines indicate CNS
expression of Pax6b.
(I–N) pnocb ATG (I–K) or control (L–N) MO-injected embryos were incubated in DMSO (I and L) or Noc peptide (J, K, M, and N). Dotted lines indicate CNS Pax6b
expression.
(O–Q) Embryos were injected with control (O) or pnocb MOs (P and Q). At 24 hpf (frontal views), Pitx3 expression reveals asymmetric, small (P; arrowhead) or
almost absent lenses (Q; arrowhead).
(legend continued on next page)
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mediating this process in amniotes and anamniotes (Figure 4T).
Mesendoderm-derived SST promotes aPP identity in the over-
lying ectoderm by regulating Eya2 andNoc. In turn, Noc controls
its own expression and, together with SST, the onset of Pax6, a
key regulator of eye and olfactory fates.
Mice lacking Noc, SST, and their receptors have been gener-
ated (Ko¨ster et al., 1999; Low et al., 2001; Nishi et al., 1997;
Zeyda et al., 2001; Zeyda and Hochgeschwender, 2008). Adult
animals do not display obvious sense organ phenotypes, for
which several other explanations are possible. First, the mutants
have not been examined for defects in lens and olfactory progen-
itors—the effects of the mutants may be transient or subtle. With
respect to SST, a robust phenotype would only be expected
when all four SSTRs expressed in sensory progenitors are abla-
ted. Furthermore, a second peptide, cortistatin, is often coex-
pressed with SST, signals through all SSTRs, and may thus
compensate for the absence of SST (Gahete et al., 2008; Zeyda
and Hochgeschwender, 2008). Finally, the mammalian Noc pre-
propeptide contains a second peptide, nocistatin, a Noc antag-
onist, which is absent in nonmammalian vertebrates (Danielson
et al., 2001; Okuda-Ashitaka et al., 1998). This may account for
subtle or lack of phenotype in mice. Here, using different tools
including tissue ablation, morpholinos, and drugs to interfere
with SST and Noc function, we reveal their role in aPP specifica-
tion. Whether neuropeptides have a similar function in rodents
and other mammals remains to be discovered; however, our
results are consistent in both amniotes and anamniotes.
Once placode progenitors are specified, they have an autono-
mous tendency to form a lens when cultured in isolation, regard-
less of their later fate (Bailey et al., 2006). They do so by initiating
Pax6 followed by the transcription factors controlling lens-spe-
cific d-crystallin. However, in the embryo, pPPs never express
Pax6 and never contribute to the lens, suggesting that, in
these cells, aPP character must be actively repressed. Here,
we show that this is indeed the case: signals from the posterior
head mesoderm inhibit aPP-specific genes partly through FGF
(this study). When grafted anteriorly, the same mesoderm
induces posterior character in the adjacent ectoderm (Kil et al.,
2005). In contrast, anterior mesendoderm promotes anterior pla-
code identity, andwe show that SST signaling participates in this
process by initiating Noc and Pax6 expression. Thus, signals
from the underlying mesoderm play a crucial role in patterning
the placode progenitor field along the rostro-caudal axis.
In agreement with their role in aPP specification, SST, Noc,
and their respective receptors are expressed prior to Pax6,
and their loss leads to severe reduction of the lens. However,
they are likely to act in concert with other signals to impart ante-
rior identity: Wnt and BMP attenuation is important for placode
progenitor induction (Ahrens and Schlosser, 2005; Brugmann
et al., 2004; Litsiou et al., 2005), whereas retinoic acid, BMP7,
and FGF-like signals have been implicated in forebrain
patterning (Dale et al., 1997; Halilagic et al., 2003; Sanchez-
Arrones et al., 2012). Our data show that SST and Noc specif-(R) Graph shows Pax6b reduction after SST inhibition, SST and Noc inhibition, in N
are at the top. Brown bars indicate embryos with phenotype, blue bars show no
(S) Quantification of pnocb morphants with Pitx3 reduction (yellow) or loss (brow
(T) Model for neuropeptide function.
Deveically control placodal fate, without affecting neural plate
patterning. Together, these observations suggest that spatial
and temporal integration of different pathways is crucial in aPP
specification and in establishing the differences between neural
and nonneural components of the cranial sensory nervous
system.
Neuropeptides and neurotransmitters are ancient signaling
molecules already present in primitive deuterostomes and other
invertebrates (Buznikov et al., 2005, 2010; Coates et al., 2000;
Conzelmann et al., 2011; Elphick, 2010; Elphick and Thorndyke,
2005; Hauser et al., 2006, 2008). They predate the origin of the
CNS. In these systems, they control proliferation and growth
(Lauder, 1993); neurotransmitters like serotonin control oocyte
maturation and cleavage as well as neuronal differentiation and
function (Buznikov et al., 2005, 2010). In vertebrates, nonneuro-
nal functions of serotonin include craniofacial development and
left-right asymmetry (Levin et al., 2006; Reisoli et al., 2010).
The opioid system appeared about 450 million years ago with
the emergence of gnathostomes (Larhammar et al., 2009),
whereas other neuropeptides were already present earlier
(Coates et al., 2000; Elphick, 2010; Elphick and Thorndyke,
2005; Hauser et al., 2006, 2008). Our findings define unexpected
functions for SST and Noc signaling in vertebrate embryos
outside the CNS, where they influence cell fate and tissue
morphogenesis, suggesting that these may be the ancestral
roles of these small molecules, whose functions in the nervous
system were co-opted much later during evolution.
EXPERIMENTAL PROCEDURES
Chick Embryo Experiments
All chick experiments involve embryos younger than E10 and do not require a
UK Home Office license. Embryos were cultured in New (Stern and Ireland,
1981) or Cornish (Nagai et al., 2011) pastry culture. Mesendoderm ablations
were performed at HH5. Beads coated with SST, nociceptin, or DMSO
(control) were grafted into the ablated area.
CSST (cyclo(7-aminoheptanoyl-Phe-D-Trp-Lys-Thr[Bzl]); Sigma-Aldrich)
and naloxone (Sigma-Aldrich) were prepared in DMSO (1 mM), UFP101
(Sigma-Aldrich) in H2O (1 mM). For inhibition studies, embryos were preincu-
bated for 1 hr in SST and/or Noc antagonists (1 mMeach) or DMSO (0.1%; con-
trol) and cultured in their presence for 5–60 hr. For knockdown, experiments
were performed using MOs (Gene Tools), which were electroporated as
described by Voiculescu et al. (2008).
HH5+-6 pPP explants were cultured as described by Bailey et al. (2006).
Collagen gels and culturemediawere supplemented as required with nocicep-
tin antagonists, nociceptin, MOs, FGF2, or SU5402. For coculture with poste-
rior head mesoderm, pPP and mesoderm were dissected separately and
recombined before culture.
Embryos and explants were processed for in situ hybridization (Streit et al.,
1998) using DIG-labeled antisense probes. For histological sections, embryos
were embedded in paraffin and sectioned transversally at 15 mm.
NanoString nCounter
For each experimental condition, eight to ten pPP explants were lysed in lysis
buffer (Ambion). Total RNA was hybridized with capture and reporter probes
according to the nCounter Gene Expression Assay Manual. Following
washing, target/probe complexes were immobilized for data collection in the
nCounter Digital Analyzer. Each experiment was repeated three times onocmorphants and Nocmorphants + Noc peptide. Numbers for each treatment
rmal embryos.
n) at early somite stages or 24 hpf.
lopmental Cell 26, 195–203, July 29, 2013 ª2013 Elsevier Inc. 201
Developmental Cell
Neuropeptides in Olfactory and Lens Precursorsindependent occasions. Mean value ± SD for Pax6 and Noc was extracted
from the normalized data.
Cloning of Zebrafish pnocb and Functional Experiments
All zebrafish studies were performed with approval from the UK Home Office
under a HO project license to C.H. Zebrafish pnocb was cloned by RT-PCR
from 48 hpf embryo cDNA. pnoc or control MOs were injected at the one- to
four-cell stage at a concentration of 1.8 ng/embryo. Embryos were grown at
28C until the desired stage. For inhibition and rescue experiments, dechorio-
nated embryos were incubated in appropriate compounds from 4 to 5 hpf until
they had reached the desired stage.
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